Cilostazol and freedom from amputation after lower extremity revascularization J. David Neel, MD, Robin L. Kruse, PhD, Viktor Y. Dombrovskiy, MD, PhD, MPH, Todd R. Vogel, MD, MPH Journal of Vascular Surgery Volume 61, Issue 4, Pages 960-964 (April 2015) DOI: 10.1016/j.jvs.2014.11.067 Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Fig 1 Crude amputation rates after lower extremity revascularization (LER), with and without cilostazol, in patients undergoing (A) endovascular repair and (B) open surgery. Journal of Vascular Surgery 2015 61, 960-964DOI: (10.1016/j.jvs.2014.11.067) Copyright © 2015 Society for Vascular Surgery Terms and Conditions
Fig 2 One-year freedom from amputation after lower extremity revascularization (LER) is shown in patients with and without cilostazol. The numbers represent the proportion of 1-year freedom from amputation with the standard error. Journal of Vascular Surgery 2015 61, 960-964DOI: (10.1016/j.jvs.2014.11.067) Copyright © 2015 Society for Vascular Surgery Terms and Conditions